A novel topical gel, HT-001, has shown potential as a treatment for cutaneous side effects from epidermal growth factor ...
In this presentation from OSN New York Retina, Majda Hadziahmetovic, MD, of Duke University, discusses the growing role of ...
OrthoIndy, Tri-State Orthopaedics and Fort Wayne Orthopedics have announced a merger to form OrthoIndiana, an integrated ...
NYU Langone announced the acquisition of Rothman Orthopaedics of Greater New York. The acquisition integrates 13 new ...
Ravi Salgia, MD, PhD, and his family were watching coverage of the Los Angeles County fires on their television around 6 p.m.
The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally ...
The FDA has granted priority review to a Biologics License Application for nipocalimab to treat individuals with generalized ...
Since entering the allergy field, Priya J. Bansal, MD, FAAAAI, FACAAI, has seen positive changes, including the entry of more ...
For the second year in a row, the CDC’s annual STI report showed an overall decline in combined cases of the three nationally ...
New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...
Recurrence-free survival and overall survival were more common in patients with nevus-associated acral melanoma compared with ...
Results showed treatment of degenerative spondylolisthesis in agreement with surgeon recommendations to perform decompression ...